A detailed history of Asset Planning,Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Asset Planning,Inc holds 1,976 shares of ABBV stock, worth $399,310. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,976
Holding current value
$399,310
% of portfolio
0.27%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$164.99 - $203.87 $326,020 - $402,847
1,976 New
1,976 $351 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Asset Planning,Inc Portfolio

Follow Asset Planning,Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Planning,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Asset Planning,Inc with notifications on news.